The closing price of Navitas Semiconductor Corp (NASDAQ: NVTS) was $4.19 for the day, down -3.01% from the previous closing price of $4.32. On the day, 4603452 shares were traded.
Ratios:
Our analysis of NVTS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.68 and its Current Ratio is at 4.14. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On August 29, 2023, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $9.20.
On February 24, 2022, Rosenblatt started tracking the stock assigning a Buy rating and target price of $15.Rosenblatt initiated its Buy rating on February 24, 2022, with a $15 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 14 ’24 when Sheridan Eugene sold 38,431 shares for $4.80 per share. The transaction valued at 184,507 led to the insider holds 3,061,631 shares of the business.
Kinzer Daniel M. sold 24,073 shares of NVTS for $115,574 on Mar 14 ’24. The COO and CTO now owns 4,538,353 shares after completing the transaction at $4.80 per share. On Mar 14 ’24, another insider, Singh Ranbir, who serves as the EVP, GeneSiC Business of the company, sold 10,925 shares for $4.80 each. As a result, the insider received 52,451 and left with 29,357 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 9.45 while its Price-to-Book (P/B) ratio in mrq is 1.97.
Stock Price History:
Over the past 52 weeks, NVTS has reached a high of $11.16, while it has fallen to a 52-week low of $4.16.
Shares Statistics:
A total of 179.20M shares are outstanding, with a floating share count of 117.97M. Insiders hold about 34.19% of the company’s shares, while institutions hold 41.60% stake in the company.
Earnings Estimates
The firm’s stock currently is rated by NVDS analysts. The consensus estimate for the next quarter is $94.41, with high estimates of $74.23 and low estimates of $4.19.
Analysts are recommending an EPS of between $Industrials and $Technology for the fiscal current year, implying an average EPS of $Healthcare.
